title: [Dynamic analysis of expression of VEGF and its receptor-2 in mouse model with acute myeloid leukemia].
abstract: The objective of study was to explore the role of vascular endothelial growth factor (VEGF) and its receptor-2 in pathogenesis of acute myeloid leukemia. The acute myeloid leukemia model was established on 20 mice with severe combined immunodeficiency (SCID) transplanted by HL-60 cells. The mice were divided into the normal control and test group randomly. The expression of VEGF was detected by enzyme linked immunosorbent assay (ELISA). The expression of VEGFR-2 mRNA was detected by RT-PCR. The results showed that the establishment of acute myeloid leukemia model was succeeded on all SCID mice by HL-60 cell transplantation. The expressions of VEGF and VEGFR-2 mRNAs could be determined on all mice. As compared with the normal control group, the expressions of VEGF and VEGFR-2 mRNAs in the test group significantly increased, but gradually increased during the course of disease. It is concluded that the abnormal expressions of VEGF and VEGFR-2 exist in mice with acute myeloid leukemia, which may be involved in the pathogenesis of AML.
authors.affiliation: Department of Pediatrics, Hospital Affiliated to Guangdong Medical College, Zhanjiang 524001, Guangdong Province, China. crl319@yahoo.com.cn
authors.forename: Ri-Ling
authors.initials: RL
authors.lastname: Chen
authors.forename: Ming-Zhen
authors.initials: MZ
authors.lastname: Chen
authors.forename: Qian-Ying
authors.initials: QY
authors.lastname: Yie
authors.forename: Chuan
authors.initials: C
authors.lastname: Tian
authors.forename: Huan
authors.initials: H
authors.lastname: Wang
mesh_terms: D000818:Animals; D001853:Bone Marrow / Q000473:pathology; D018922:HL-60 Cells; D006801:Humans; D051379:Mice; D016513:Mice, SCID; D009368:Neoplasm Transplantation; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*
chemical_list: D042461:Vascular Endothelial Growth Factor A; D040301:Vascular Endothelial Growth Factor Receptor-2